The proliferation of cancer cells in this trial was reduced by the application of both HBOT and chemotherapy (5-FU). However, the combination of the 2 resulted in a marked and significant synergism in the reduction of cancer cell proliferation. HBOT’s role in this chemosensitization may be a powerful addition to current cancer practices <view study> Read Less